Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human GDF6 ELISA Kit (AC3680)
Cat.#: ASET-2269
Specifications
Description Human GDF6 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human GDF6 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.54 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2409 Mouse Ornithine Aminotransferase ELISA Kit (AC3820) Quantitative inquiry ASET-1450 Human KCC2 ELISA Kit (AC2861) Quantitative inquiry ASET-1689 Human GABA A Receptor alpha 1 ELISA Kit (AC3100) Quantitative inquiry ASET-1763 Human IMPA1 ELISA Kit (AC3174) Quantitative inquiry ASET-2482 Mouse ApoER2 ELISA Kit (AC3893) Quantitative inquiry ASET-1670 Human Histidine Decarboxylase ELISA Kit (AC3081) Quantitative inquiry ASET-2136 Human 5HT2A Receptor ELISA Kit (AC3547) Quantitative inquiry ASET-1380 Rat FGF2 ELISA Kit (AC2791) Quantitative inquiry ASET-1764 Human NRG1 ELISA Kit (AC3175) Quantitative inquiry ASET-1530 Human Neuritin ELISA Kit (AC2941) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket